Evidence map›Paper›PMID 33206726›Full record

ArticlePloS one2020

TGF-β-induced activation of conjunctival fibroblasts is modulated by FGF-2 and substratum stiffness.

Tomoyo Matsumura, Tomokazu Fujimoto, Akiko Futakuchi, Yuji Takihara, Fumika Watanabe-Kitamura, Eri Takahashi, Miyuki Inoue-Mochita, Hidenobu Tanihara, Toshihiro Inoue

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Inhibition of mTOR differently modulates planar and subepithelial fibrogenesis in human conjunctival fibroblasts.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Anti-fibrotic effects of pharmacologic FGF-2: a review of recent literature.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tomoyo MatsumuraDepartment of Ophthalmology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Tomokazu FujimotoDepartment of Ophthalmology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Akiko FutakuchiDepartment of Ophthalmology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yuji TakiharaDepartment of Ophthalmology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Fumika Watanabe-KitamuraDepartment of Ophthalmology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Eri TakahashiDepartment of Ophthalmology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Miyuki Inoue-MochitaDepartment of Medical Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan.
Hidenobu TaniharaDirector of Hospital, Kumamoto University Hospital, Kumamoto, Japan.
Toshihiro InoueDepartment of Ophthalmology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.ORCID 0000-0003-3769-7609
Kumamoto University · JPKumamoto University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to investigate the effects of substratum stiffness on the sensitivity of human conjunctival fibroblasts to transforming growth factor (TGF)-β, and to explore the molecular mechanism of action.

methodsHuman conjunctival fibroblasts were cultured on collagen-coated plastic or silicone plates. The stiffness of the silicone plates was 0.2 or 64 kPa. Cells were treated by 2.5 ng/mL TGF-β2 with or without fibroblast growth factor (FGF)-2 (0-100 ng/mL) for 24 h or 48 h. The protein expression levels were determined by Western blot analysis. Cell proliferation was assessed using the WST-8 assay.

resultsFGF-2 suppressed the TGF-β-induced expression of α-smooth muscle actin (SMA) and collagen type I (Col I), but not fibronectin (FN). Both FGF-2 and TGF-β2 increased cell proliferation without an additive effect. The induction of α-SMA by TGF-β2 was decreased on the soft substratum, without any change in the expression level or subcellular location of Yes-associated protein/transcriptional coactivator with PDZ-binding motif (YAP/TAZ). FGF-2 suppressed TGF-β-induced α-SMA expression even on the soft substratum.

conclusionsFGF-2 treatment and a soft substratum suppressed TGF-β-induced transdifferentiation of conjunctival fibroblasts into myofibroblasts. FGF-2 attenuated the TGF-β-induced expression of α-SMA, even on a soft substratum.

Indexed as

Cell ProliferationCell TransdifferentiationGene Expression RegulationActinsAdaptor Proteins, Signal TransducingCell LineCollagen Type IConjunctivaFibroblast Growth Factor 2HumansMyofibroblastsTranscription FactorsTransforming Growth Factor beta2YAP-Signaling ProteinsActinsAdaptor Proteins, Signal TransducingCollagen Type IFibroblast Growth Factor 2TGFB2 protein, humanTranscription FactorsTransforming Growth Factor beta2YAP1 protein, humanYAP-Signaling Proteins

Identifiers

PMID33206726
PMCPMC7673499
OpenAlexW3099500778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.